Outcomes of a Dose-Escalated Stereotactic Body Radiation Phase 1 Trial for Patients With Low- and Intermediate-Risk Prostate Cancer

• Published in: International journal of radiation oncology, biology, physics Vol. 104; no. 2; pp. 334 - 342
• Main Authors: Potters, Louis, Rana, Zaker, Lee, Lucille, Cox, Brett W.
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 01.06.2019

This study presents a prospective phase 1, institutional review board–approved dose-escalated stereotactic body radiation therapy trial for prostate cancer (CaP) to assess the impact of dose level on quality of life, toxicity, and clinical outcomes. From 2011 to 2016, 26 patients with low- and inter...